Pay in 4 interest-free payments of $5.84 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
The SURMOUNT clinical program demonstrated substantial weight reductions establishing tirzepatide as one of the most effective obesity medications available
Vogl DT, Younes A, Stewart K, Orford KW, Berdeja JG
Evidence from a 72-week study showed that Tirzepatide led participants to lose an average of weight reductions between 15% to 21% of their body weight, a significant reduction compared to the 3% loss observed in the placebo group
This program is designed for people who dont achieve their weight loss goals by exercising and dieting
US$ 25.33
US$ 20.64
US$ 23.74
US$ 23.88
